Results 21 to 30 of about 34,150 (283)

The Effects of Pentoxifylline on Memory in Male Rats Treated with Zinc Oxide NPs

open access: yesThe Journal of Qazvin University of Medical Sciences, 2021
Background: Zinc oxide Nanoparticles (NPs) present irreversible effects on the nervous system, memory, and learning. Objective: The current study aimed to investigate the effects of pentoxifylline on memory impairments, CA1 hippocampal pyramidal cells,
Niloufar Darbandi   +2 more
doaj   +1 more source

Treatment of COVID‐19 with pentoxifylline: Could it be a potential adjuvant therapy?

open access: yesDermatologic Therapy, 2020
The world is facing a viral pandemic of a new coronavirus called COVID‐19. Pentoxifylline is a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV).
Farnoosh Seirafianpour   +5 more
semanticscholar   +1 more source

The effects of pentoxifylline and tocopherol in jaw osteomyelitis

open access: yesJournal of the Korean Association of Oral and Maxillofacial Surgeons, 2020
Objectives Pentoxifylline (PTX) is a methylxanthine derivative that has been implicated in the pathogenesis of peripheral vessel disease and intermittent lameness.
M. Seo   +4 more
semanticscholar   +1 more source

Hemodialysis membrane-related neutrophil dysfunctions and pentoxifylline - a pilot study [PDF]

open access: yes, 1990
Hemodialysis treatment is associated with activation of neutrophil granulocytes. Pentoxifylline has been shown to inhibit neutrophil activation in vitro and in vivo.
Hoffmann, H.   +3 more
core   +1 more source

Can Pentoxifylline be used as Adjunct Therapy to ACE Inhibitors and ARBs in Preserving Kidney Function?

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2016
Purpose. To determine if there is sufficient evidence to recommend the addition of pentoxifylline to standard ACE inhibitor and ARB therapy in chronic kidney disease patients to reduce proteinuria and preserve kidney function.
Cody Carson   +2 more
doaj   +1 more source

cAMP-Inhibits Cytoplasmic Phospholipase A(2) and Protects Neurons against Amyloid-beta-Induced Synapse Damage [PDF]

open access: yes, 2015
A key event in Alzheimer’s disease (AD) is the production of amyloid-β (Aβ) peptides and the loss of synapses. In cultured neurons Aβ triggered synapse damage as measured by the loss of synaptic proteins. α-synuclein (αSN), aggregates of which accumulate
Bate, C, Williams, A
core   +2 more sources

Investigating the Effect of Pentoxifylline and Zinc Oxide Combination on Experimental Full-Thickness Wound Healing in Rats [PDF]

open access: yesIranian Journal of Veterinary Surgery, 2023
This paper aims to investigate the effect of topical application of pentoxifylline and zinc oxide combination on experimental full-thickness wound healing in rats.
Mahzad Moradi   +3 more
doaj   +1 more source

Silence of the limbs: pharmacological symptomatic treatment of intermittent claudication [PDF]

open access: yes, 2010
Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules.
De Backer, Gui   +4 more
core   +1 more source

Effectiveness of pentoxifylline in severe early-onset fetal growth restriction: A randomized double-blinded clinical trial

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2022
Objective: Management of pregnancy complicated by severe early-onset fetal growth restriction (FGR) is one of the most challenging obstetrical issues. So far, there has not been a proven option for the treatment or improvement of this condition. Improper
Nasrin Asadi   +13 more
doaj   +1 more source

Impending anterior ischemic optic neuropathy with elements of retinal vein occlusion in a patient on interferon for polycythemia vera. [PDF]

open access: yes, 2012
We describe the course and likely pathophysiology of impending anterior ischemic optic neuropathy (AION) and retinal vein occlusion in a 56-year-old man with polycythemia vera managed with interferon alpha for 2 years.
Hirsch, Louis K   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy